GREY:ATTBF - Post by User
Post by
1234ZIONon Apr 02, 2019 11:09am
471 Views
Post# 29569822
Commission Reply
Commission ReplyThank you for your inquiry to the Ontario Securities Commission (OSC) concerning Abattis Bioceuticals Corp. (Abbatis). You are looking for more information about the recent Cease Trade Order (CTO) issued against Abbatis. Abbatis is a reporting issuer in Ontario and the British Columbia Securities Commission (BCSC) is the principal regulator for this company. One of the main requirements for reporting issuers is to file continuous disclosure required under Ontario securities law on the System for Electronic Document Analysis & Retrieval (SEDAR) at: www.sedar.com. Abbatis has been the subject of a ceased trade order (CTO) in Ontario since February 1, 2019. A CTO is typically issued when a reporting issuer has failed to make timely disclosure and shares of that company cannot be traded until such time as the company files an application to have the CTO removed, brings its filings up-to-date and pays outstanding fees. You can review the CTO at this link:https://cto-iov.csa-acvm.ca/ArticleFile.asp?Instance=101&ID=3352DAEBC4AF48BBB300D1E677B44F75.